EA
BLFS icon

Evolution Advisers’s BioLife Solutions BLFS Stock Holding History

Evolution Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+4
New +$93 ﹤0.01% 296

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Evolution Advisers's BLFS Position: Q2 2026 in Review

Evolution Advisers opened a new position in BioLife Solutions (BLFS) in Q2 2026: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #296 among its holdings.

216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Evolution Advisers held 4 shares of BioLife Solutions worth $0 as of Q2 2026.
  • BioLife Solutions was a new Evolution Advisers position in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #296 holding.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.